Approvals/TGA/IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Approved

STANDARD

IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial

Accord Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 77637934fec5acfe
Product Name: IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Artg Id: 316415
Artg Name: IRINOTECAN ACCORD irinotecan hydrochloride trihydrate 300 mg/15 mL concentrated injection vial
Sponsor: Accord Healthcare Pty Ltd
Company Detail Path: /organization/accord-healthcare-pty-ltd
Artg Date: 2020-03-05
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/1536d871c2cee949b5ca17c47f79fff5.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/504b14ecf64ec7fc68432b0d15f711a5.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

77637934fec5acfe

Type

Standard